بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significantly longer » significantly lower (توسيع البحث), significantly larger (توسيع البحث), significantly higher (توسيع البحث)
longer decrease » larger decrease (توسيع البحث), linear decrease (توسيع البحث), largest decrease (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
significantly longer » significantly lower (توسيع البحث), significantly larger (توسيع البحث), significantly higher (توسيع البحث)
longer decrease » larger decrease (توسيع البحث), linear decrease (توسيع البحث), largest decrease (توسيع البحث)
-
121
Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX
منشور في 2024"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"
-
122
DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
منشور في 2024"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"
-
123
DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
منشور في 2024"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"
-
124
DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
منشور في 2024"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"
-
125
DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
منشور في 2024"…HC 8.5 vs. 5.5, p = 0.0036), longer wakefulness after sleep onset (MASLD vs. HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. …"
-
126
-
127
-
128
-
129
-
130
-
131
Ubiquitination of PoAce1 and effect of proteasome inhibitor MG132 on PoAce1.
منشور في 2025الموضوعات: -
132
-
133
-
134
The phenotype of the Δ<i>ace1</i> and (hemi)cellulase production of various mutants.
منشور في 2025الموضوعات: -
135
-
136
PoAce1 enrichment in the specific regions of (hemi)cellulase genes assayed by ChIP-qPCR.
منشور في 2025الموضوعات: -
137
-
138
Construction strategies for GFP strains Ace1/Fbx23-GFP and BiFC strain Ace1-YFP-Fbx23.
منشور في 2025الموضوعات: -
139
Construction strategy and verification of strains Ace1/Fbx23-TAP, Δ<i>fbx23</i>, and Re<i>fbx23</i>.
منشور في 2025الموضوعات: -
140